Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LORAZEPAM Cause Labelled drug-drug interaction issue? 28 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Labelled drug-drug interaction issue have been filed in association with LORAZEPAM (Lorazepam). This represents 0.1% of all adverse event reports for LORAZEPAM.

28
Reports of Labelled drug-drug interaction issue with LORAZEPAM
0.1%
of all LORAZEPAM reports
15
Deaths
2
Hospitalizations

How Dangerous Is Labelled drug-drug interaction issue From LORAZEPAM?

Of the 28 reports, 15 (53.6%) resulted in death, 2 (7.1%) required hospitalization, and 2 (7.1%) were considered life-threatening.

Is Labelled drug-drug interaction issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LORAZEPAM. However, 28 reports have been filed with the FAERS database.

What Other Side Effects Does LORAZEPAM Cause?

Drug ineffective (3,775) Drug abuse (3,741) Toxicity to various agents (2,836) Completed suicide (2,340) Off label use (2,178) Somnolence (2,114) Sopor (2,042) Anxiety (1,573) Fall (1,524) Overdose (1,516)

What Other Drugs Cause Labelled drug-drug interaction issue?

ASPIRIN (75) QUETIAPINE (70) BUPROPION\NALTREXONE (65) POSACONAZOLE (47) BUPROPION (42) CLOPIDOGREL BISULFATE (42) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (42) RIVAROXABAN (39) OMEPRAZOLE (37) TACROLIMUS (37)

Which LORAZEPAM Alternatives Have Lower Labelled drug-drug interaction issue Risk?

LORAZEPAM vs LORCASERIN LORAZEPAM vs LORLATINIB LORAZEPAM vs LORMETAZEPAM LORAZEPAM vs LORNOXICAM LORAZEPAM vs LOSARTAN

Related Pages

LORAZEPAM Full Profile All Labelled drug-drug interaction issue Reports All Drugs Causing Labelled drug-drug interaction issue LORAZEPAM Demographics